HeimIUI1 • FRA
add
Intuitive Surgical, Inc.
Við síðustu lokun
518,70 €
Dagbil
516,60 € - 521,90 €
Árabil
291,80 € - 535,20 €
Markaðsvirði
190,79 ma. USD
Meðalmagn
120,00
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 2,04 ma. | 16,88% |
Rekstrarkostnaður | 796,60 m. | 13,57% |
Nettótekjur | 565,10 m. | 35,94% |
Hagnaðarhlutfall | 27,73 | 16,32% |
Hagnaður á hvern hlut | 1,84 | 26,03% |
EBITDA | 693,50 m. | 20,73% |
Virkt skatthlutfall | 14,96% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 4,23 ma. | -34,65% |
Heildareignir | 17,74 ma. | 20,60% |
Heildarskuldir | 2,07 ma. | -1,12% |
Eigið fé alls | 15,68 ma. | — |
Útistandandi hlutabréf | 356,18 m. | — |
Eiginfjárgengi | 11,86 | — |
Arðsemi eigna | 8,39% | — |
Ávöxtun eigin fjár | 9,47% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 565,10 m. | 35,94% |
Handbært fé frá rekstri | 706,50 m. | 28,83% |
Reiðufé frá fjárfestingum | -1,41 ma. | -216,39% |
Reiðufé frá fjármögnun | 98,20 m. | 58,90% |
Breyting á handbæru fé | -620,50 m. | -475,38% |
Frjálst peningaflæði | 516,81 m. | 105,39% |
Um
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.
Intuitive Surgical made its debut on the Fortune 500 list in 2024, ranking #497. Wikipedia
Framkvæmdastjóri
Stofnsett
1995
Höfuðstöðvar
Vefsvæði
Starfsfólk
13.676
